Intranasal prime-boost RNA vaccination elicits potent T cell response for lung cancer therapy
{{output}}
The rapid success of RNA vaccines in preventing SARS-CoV-2 has sparked interest in their use for cancer immunotherapy. Although many cancers originate in mucosal tissues, current RNA cancer vaccines are mainly administered non-mucosally. Here, we developed a n... ...
